Laura Gault - 16 Jan 2025 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SAGE	Common Stock	Award	$0	+24,000	+212%	$0.000000	35,334	16 Jan 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Consists of shares of common stock issuable under 24,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on January 16, 2026.
F2	Reflects beneficial ownership balance which includes 597 shares purchased on December 31, 2024 under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.